Kiwa Bio-Tech Products Group Corp (fka KWBT)

[operating_line]

Expected economic growth in China in 2021 supports the top down approach for a possible investment in KWBT. I can only infer from the August PR that we might get the Q3 filing on time rather than late since it appeared management were reassuring shareholders on this topic. If so, that Q3 filing could be around mid-November when comparing to 2019. With that filing, we can expect Q1 and Q2 at the same time to get them up to date.